Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Carrier Global
CARR
$48.2B
| $987K | ﹤0.01% |
18,670
-4,085
| -18% | -$227K |
|
2152
CALL
Neuronetics
STIM
$227M
| $984K | ﹤0.01% |
713,300
-566,200
| -44% | -$1.18M |
|
2153
CALL
WEC Energy
WEC
$34.8B
| $981K | ﹤0.01% |
+9,300
| New | +$1.03M |
|
|
AMWD
2154
DELISTED
American Woodmark
AMWD
| $980K | ﹤0.01% |
18,186
+15,096
| +489% | +$884K |
|
2155
CALL
Southern Company
SO
$103B
| $977K | ﹤0.01% |
+11,200
| New | +$1.02M |
|
2156
CorVel
CRVL
$3.54B
| $973K | ﹤0.01% |
14,383
+11,180
| +349% | +$810K |
|
2157
Illinois Tool Works
ITW
$80.2B
| $973K | ﹤0.01% |
3,951
-1,834
| -32% | -$457K |
|
2158
State Street Consumer Staples Select Sector SPDR ETF
XLP
$15.1B
| $969K | ﹤0.01% |
12,480
-14,089
| -53% | -$1.1M |
|
2159
CALL
Enphase Energy
ENPH
$4.94B
| $968K | ﹤0.01% |
30,200
| – | – |
|
2160
PUT
SoundHound AI
SOUN
$3.13B
| $967K | ﹤0.01% |
97,000
+86,200
| +798% | +$1.24M |
|
2161
iQIYI
IQ
$994M
| $964K | ﹤0.01% |
+501,883
| New | +$1.07M |
|
|
MFA
2162
MFA Financial
MFA
$894M
| $962K | ﹤0.01% |
103,284
-622,289
| -86% | -$5.8M |
|
2163
Hubbell
HUBB
$24.5B
| $960K | ﹤0.01% |
2,161
-52,445
| -96% | -$23M |
|
2164
Gates Industrial Corp
GTES
$6.57B
| $959K | ﹤0.01% |
44,681
-210,554
| -82% | -$4.86M |
|
2165
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.55B
| $959K | ﹤0.01% |
+29,197
| New | +$958K |
|
2166
PUT
CME Group
CME
$99.7B
| $956K | ﹤0.01% |
3,500
+2,100
| +150% | +$571K |
|
2167
Universal Technical Institute
UTI
$1.24B
| $956K | ﹤0.01% |
36,573
-38,259
| -51% | -$1.08M |
|
2168
Independent Bank Corp
IBCP
$815M
| $951K | ﹤0.01% |
+29,233
| New | +$939K |
|
2169
CALL
Cisco
CSCO
$438B
| $947K | ﹤0.01% |
12,300
-340,600
| -97% | -$25.3M |
|
2170
PUT
BridgeBio Pharma
BBIO
$15.7B
| $941K | ﹤0.01% |
12,300
| – | – |
|
2171
PUT
BILL Holdings
BILL
$4.75B
| $938K | ﹤0.01% |
17,200
+5,800
| +51% | +$298K |
|
2172
Darden Restaurants
DRI
$25B
| $937K | ﹤0.01% |
5,090
-391,091
| -99% | -$71.3M |
|
2173
Hancock Whitney
HWC
$5.99B
| $933K | ﹤0.01% |
14,658
+1,829
| +14% | +$111K |
|
2174
Chord Energy
CHRD
$7.7B
| $932K | ﹤0.01% |
10,053
+1,903
| +23% | +$176K |
|
|
MMD
2175
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$282M
| $931K | ﹤0.01% |
+62,636
| New | +$940K |
|
Similar funds
Dmitry Balyasny's Q4 2025 Portfolio in Review
As of Q4 2025, Dmitry Balyasny held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Dmitry Balyasny withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Dmitry Balyasny opened a new position in Avidity Biosciences worth $436M.
- Dmitry Balyasny's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Dmitry Balyasny added most to Amazon in Q4 2025, an estimated $807M increase.
- Dmitry Balyasny's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Dmitry Balyasny fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Dmitry Balyasny's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Dmitry Balyasny opened 809 new positions and closed 643 in Q4 2025.
- Dmitry Balyasny's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.